|
EP3378486B1 |
03 Mar, 2021
|
Stabilized Antibody-Containing Liquid Formulations
|
Jan, 2031
|
5
| |
|
EP2647707B1 |
12 Sep, 2018
|
Cytotoxicity-Inducing Therapeutic Agent
|
Nov, 2031
|
5
| |
|
EP2154244B1 |
12 Apr, 2017
|
Cell Culture Method Using Amino Acid-Enriched Medium
|
Apr, 2028
|
5
| |
|
EP3130606B1 |
13 Oct, 2021
|
Immunoactivating Antigen-Binding Molecule
|
Apr, 2035
|
2
| |
|
EP3056568B1 |
15 Sep, 2021
|
Methods For Controlling Blood Pharmacokinetics Of Antibodies
|
Mar, 2027
|
2
| |
|
EP3342786B1 |
23 Jun, 2021
|
Anti-Dll3 Antibody
|
Jan, 2031
|
2
| |
|
EP2698431B1 |
09 Sep, 2020
|
Retention Of Antigen-Binding Molecules In Blood Plasma And Method For Modifying Immunogenicity
|
Mar, 2032
|
2
| |
|
EP3330279B1 |
06 Apr, 2022
|
Method For Purifying Composition Comprising Antibodies With Anionic Polymer
|
Jul, 2036
|
1
| |
|
EP3296395B1 |
30 Jun, 2021
|
Multiple Antigen Binding Molecular Fusion, Pharmaceutical Composition, Method For Identifying Linear Epitope, And Method For Preparing Multiple Antigen Binding Molecular Fusion
|
May, 2036
|
1
| |
|
EP2787078B1 |
22 May, 2019
|
Antigen-Binding Molecule Having Regulated Conjugation Between Heavy-Chain And Light-Chain
|
Oct, 2032
|
1
| |
|
EP2526963B1 |
25 Apr, 2018
|
Solution Preparation Containing Stabilized Antibody
|
Jan, 2031
|
1
| |
|
EP2311492B1 |
04 Oct, 2017
|
Antibody-Containing Stabilized Preparations
|
Aug, 2021
|
1
| |
